00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|126/13|
00000000|MMI|3.63|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|100/14|
00000000|MMI|3.63|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|100/14|
00000000|MMI|3.59|20%|C3842589|[fndg]|["20%"-tx-1-"20"-fraction-0]|TX|43/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.50|Congestive heart failure|C0018802|[dsyn]|["CONGESTIVE HEART FAILURE"-tx-1-"congestive heart failure"-noun-0]|TX|65/24|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|94/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|94/3|
00000000|MMI|320.89|Portugal|C0032729|[geoa]|["PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[1748/2],[2328/2];[817/2],[879/2],[946/2],[1002/2],[1093/2],[1159/2];[386/2],[450/2],[571/2],[605/2],[643/2],[711/2]|Z01.542.727
00000000|MMI|258.09|Warfarin|C0043031|[hops,orch,phsu]|["WARFARIN"-tx-5-"WARFARIN"-noun-0]|TX|[1418/8],[1478/8],[1534/8],[1596/8],[1658/8],[2008/8],[2068/8],[2124/8],[2186/8],[2248/8]|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|175.59|Mongolia|C0026410|[geoa]|["MG"-tx-5-"MG"-noun-0,"MG"-tx-5-"mg"-noun-0,"MG"-tx-4-"MG"-noun-0,"MG"-tx-4-"mg"-noun-0,"MG"-tx-3-"MG"-noun-0]|TX|1745/2;1828/2;[814/2],[876/2],[999/2],[1156/2];1237/2;[447/2],[568/2],[602/2],[640/2]|Z01.252.474.651
00000000|MMI|160.14|Coumadin|C0699129|[orch,phsu]|["Coumadin"-tx-20-"coumadin"-noun-0,"Coumadin"-tx-17-"coumadin"-noun-0,"Coumadin"-tx-8-"Coumadin"-noun-0,"Coumadin"-tx-6-"Coumadin"-noun-0,"Coumadin"-tx-5-"COUMADIN"-noun-0,"Coumadin"-tx-4-"COUMADIN"-noun-0]|TX|[5109/8],[5156/8];4792/8;2890/8;2732/8;1711/8;1124/8|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|137.42|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-27-"DISCHARGE"-noun-0,"Discharge"-tx-22-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Release"-tx-5-"RELEASE"-adj-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|5425/9;5210/9;3066/9;2344/7;344/9;40/9;122/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|114.53|Phenobarbital|C0031412|[orch,phsu]|["PHENOBARBITAL"-tx-18-"phenobarbitol"-noun-0,"PHENOBARBITAL"-tx-5-"PHENOBARBITAL"-noun-0,"PHENOBARBITAL"-tx-4-"PHENOBARBITAL"-noun-0]|TX|4910/13;[1576/13],[1638/13],[2166/13],[2228/13];858/13|D03.383.742.698.253.650
00000000|MMI|113.49|Oral|C0442027|[spco]|["PO"-tx-5-"PO"-noun-0,"PO"-tx-4-"PO"-noun-0,"PO"-tx-3-"PO"-noun-0]|TX|[1748/2],[2328/2];[817/2],[879/2],[946/2],[1002/2],[1093/2],[1159/2];[386/2],[450/2],[571/2],[605/2],[643/2],[711/2]|
00000000|MMI|97.77|Togo|C0040363|[geoa]|["TO"-tx-22-"to"-adv-0,"TO"-tx-21-"to"-noun-0,"TO"-tx-7-"to"-adv-0,"TO"-tx-5-"to"-adv-0]|TX|5265/2;5189/2;[2765/2],[2801/2],[2838/2];2420/2|Z01.058.290.190.800
00000000|MMI|97.77|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-22-"to"-adv-0,"TO"-tx-21-"to"-noun-0,"TO"-tx-7-"to"-adv-0,"TO"-tx-5-"to"-adv-0]|TX|5265/2;5189/2;[2765/2],[2801/2],[2838/2];2420/2|D08.811.520.224.800
00000000|MMI|93.46|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-18-"lasix"-noun-0,"Lasix"-tx-14-"Lasix"-noun-0,"Lasix"-tx-12-"lasix"-noun-0,"Lasix"-tx-9-"lasix"-noun-0,"Lasix"-tx-3-"LASIX"-noun-0]|TX|4989/5;4653/5;4451/5;3901/5;577/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|81.38|Aspirin|C0004057|[orch,phsu]|["ASPIRIN"-tx-5-"ASPIRIN"-noun-0,"ASPIRIN"-tx-4-"ASPIRIN"-noun-0]|TX|[1520/7],[2110/7];1062/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|74.38|International Normalized Ratio|C0525032|[lbpr]|["INR"-tx-17-"INR"-noun-0,"INR"-tx-8-"INR's"-noun-0,"INR"-tx-7-"INR"-noun-0,"INR"-tx-7-"INR's"-noun-0]|TX|4821/3;2864/5;2797/3;2832/5|E01.370.225.625.115.320;E05.200.625.115.320
00000000|MMI|62.17|Cerebrovascular accident|C0038454|[dsyn]|["CVA, NOS"-tx-18-"CVA"-noun-0,"CVA, NOS"-tx-12-"CVA"-noun-0,"CEREBROVASCULAR ACCIDENT"-tx-8-"cerebrovascular accident"-noun-0,"CVA, NOS"-tx-8-"CVA"-noun-0]|TX|4902/3;4041/3;3375/24;3369/3|C10.228.140.300.775;C14.907.253.855
00000000|MMI|61.33|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-5-"Food/Drug Interaction"-noun-0,"Interaction, Food-Drug"-tx-3-"Food/Drug Interaction"-noun-0]|TX|[1261/21],[1851/21];[487/21],[718/21]|G07.690.773.968.511
00000000|MMI|56.76|Obesity|C0028754|[dsyn]|["OBESITY"-tx-8-"Obesity"-noun-0,"OBESITY"-tx-8-"obesity"-noun-0]|TX|3477/7;3487/7|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|49.37|Panama|C0030266|[geoa]|["PM"-tx-27-"PM"-noun-0,"PM"-tx-18-"PM"-adj-0,"PM"-tx-8-"PM"-adj-0,"PM"-tx-1-"PM"-adj-0]|TX|5408/2;4889/2;3754/2;161/2|Z01.107.169.772
00000000|MMI|49.30|Honduras|C0019905|[geoa]|["HO"-tx-18-"ho"-noun-0,"HO"-tx-17-"ho"-noun-0,"HO"-tx-12-"ho"-noun-0]|TX|4899/2;[4741/2],[4769/2];4038/2|Z01.107.169.534
00000000|MMI|47.73|Simvastatin|C0074554|[orch,phsu]|["SIMVASTATIN"-tx-5-"SIMVASTATIN"-noun-0]|TX|[1460/11],[2050/11]|D02.455.426.559.847.638.400.900;D04.615.638.400.900
00000000|MMI|47.70|Vitamin K|C0042878|[orch,vita]|["VITAMIN K"-tx-5-"Vitamin-K"-noun-0]|TX|[1303/9],[1893/9]|D02.455.426.559.847.638.721.374;D02.455.849.291.523.500;D04.615.638.721.374;x.x.x.x
00000000|MMI|47.01|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-5-"MG"-noun-0,"Mg++"-tx-5-"mg"-noun-0,"Mg++"-tx-4-"MG"-noun-0,"Mg++"-tx-4-"mg"-noun-0,"Mg++"-tx-3-"MG"-noun-0]|TX|1745/2;1828/2;[814/2],[876/2],[999/2],[1156/2];1237/2;[447/2],[568/2],[602/2],[640/2]|
00000000|MMI|47.01|Milligram percent|C1960952|[qnco]|["mg %"-tx-5-"MG"-noun-0,"mg %"-tx-5-"mg"-noun-0,"mg %"-tx-4-"MG"-noun-0,"mg %"-tx-4-"mg"-noun-0,"mg %"-tx-3-"MG"-noun-0]|TX|1745/2;1828/2;[814/2],[876/2],[999/2],[1156/2];1237/2;[447/2],[568/2],[602/2],[640/2]|
00000000|MMI|47.01|mg/dL|C0439269|[qnco]|["mg%"-tx-5-"MG"-noun-0,"mg%"-tx-5-"mg"-noun-0,"mg%"-tx-4-"MG"-noun-0,"mg%"-tx-4-"mg"-noun-0,"mg%"-tx-3-"MG"-noun-0]|TX|1745/2;1828/2;[814/2],[876/2],[999/2],[1156/2];1237/2;[447/2],[568/2],[602/2],[640/2]|
00000000|MMI|45.49|Treatment Protocols|C0040808|[topp]|["Regimen"-tx-13-"regimen"-noun-0,"Regimen"-tx-5-"regimen"-noun-0]|TX|4595/7;[1703/7],[2293/7]|E02.183;N05.715.360.775.225
00000000|MMI|45.33|Ivory Coast|C0022326|[geoa]|["IV"-tx-18-"IV"-noun-0,"IV"-tx-14-"IV"-noun-0,"IV"-tx-12-"IV"-noun-0]|TX|4986/2;4650/2;4448/2|Z01.058.290.190.272
00000000|MMI|44.98|Warfarin Sodium|C0376218|[hops,orch,phsu]|["WARFARIN SODIUM"-tx-5-"WARFARIN SODIUM"-noun-0,"WARFARIN SODIUM"-tx-4-"WARFARIN SODIUM"-noun-0]|TX|1722/15;1135/15|D03.383.663.283.446.520.914;D03.438.150.446.520.914
00000000|MMI|44.98|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-8-"DIAGNOSIS"-noun-0]|TX|[3020/9],[3166/9]|x.x.x.x.x.x.x
00000000|MMI|42.06|Oxycodone|C0030049|[orch,phsu]|["OXYCODONE"-tx-4-"OXYCODONE"-noun-0]|TX|[802/9],[965/9]|D03.132.577.249.562.149.575;D03.549.686.607.204.650;D03.605.497.607.204.650;D04.615.723.795.576.149.575
00000000|MMI|42.04|paired basic amino acid cleaving enzyme|C0287990|[aapp,enzy]|["PACE"-tx-17-"paced"-noun-0,"PACE"-tx-12-"paced"-noun-0]|TX|4782/5;4126/5|D08.811.277.656.300.760.353;D08.811.277.656.837.249;D08.811.277.656.959.350.353
00000000|MMI|41.82|Coding|C0009219|[ocac]|["code"-tx-3-"CODE"-noun-0,"code"-tx-3-"code"-noun-0]|TX|291/4;309/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|41.80|Interaction|C1704675|[ftcn]|["Interaction"-tx-5-"INTERACTION"-noun-0]|TX|[1387/11],[1447/11],[1507/11],[1563/11],[1625/11],[1977/11],[2037/11],[2097/11],[2153/11],[2215/11]|
00000000|MMI|40.03|Serious|C0205404|[qlco]|["Serious"-tx-5-"SERIOUS"-adj-0]|TX|[1379/7],[1439/7],[1499/7],[1555/7],[1617/7],[1969/7],[2029/7],[2089/7],[2145/7],[2207/7]|
00000000|MMI|36.74|Diet|C0012155|[food]|["Diet"-tx-5-"DIET"-noun-0]|TX|[2506/4],[2548/4],[2582/4]|G07.203.650.240
00000000|MMI|36.68|Rabbi|C0684010|[prog]|["R."-tx-17-"R"-noun-0,"R."-tx-12-"R"-adj-0,"R."-tx-8-"R"-noun-0]|TX|4766/1;4288/1;3638/1|M01.526.799.500
00000000|MMI|33.21|Dominican Republic|C0013014|[geoa]|["DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|2750/2;2697/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|30.55|Zaroxolyn|C0701383|[orch,phsu]|["Zaroxolyn"-tx-9-"zaroxolyn"-noun-0,"Zaroxolyn"-tx-3-"ZAROXOLYN"-noun-0]|TX|3911/9;611/9|D02.065.884.600;D02.886.590.700.600;D03.438.786.830.688
00000000|MMI|30.27|Coronary Artery Bypass Surgery|C0010055|[topp]|["CABG"-tx-8-"CABG"-noun-0]|TX|[3274/4],[3731/4]|E04.100.376.719.332;E04.100.814.868.750;E04.928.220.520.220
00000000|MMI|30.07|Saint Kitts and Nevis|C0282380|[geoa]|["SC"-tx-5-"SC"-noun-0,"SC"-tx-4-"SC"-noun-0]|TX|2466/2;1047/2|Z01.107.084.900.787;Z01.639.880.787
00000000|MMI|27.83|Diet therapy|C0012159|[hlca]|["Diet"-tx-5-"DIET"-noun-0]|TX|[2506/4],[2548/4],[2582/4]|E02.642.249
00000000|MMI|27.33|Atrial Fibrillation|C0004238|[dsyn]|["AFib"-tx-8-"Afib"-noun-0,"ATRIAL FIBRILLATION"-tx-8-"atrial fibrillation"-noun-0]|TX|3340/4;3347/19|C14.280.067.198;C23.550.073.198
00000000|MMI|27.33|Costa Rica|C0010182|[geoa]|["CRI"-tx-8-"CRI"-noun-0]|TX|[3533/3],[3738/3]|Z01.107.169.238
00000000|MMI|27.33|Diabetes Mellitus|C0011849|[dsyn]|["Diabetes"-tx-18-"diabetes"-noun-0,"DIABETES MELLITUS"-tx-8-"diabetes mellitus"-noun-0]|TX|4931/8;3409/17|C18.452.394.750;C19.246
00000000|MMI|27.33|Physicians|C0031831|[prog]|["DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|2750/2;2697/2|M01.526.485.810;N02.360.810
00000000|MMI|26.64|Homo sapiens|C0086418|[humn]|["MAN"-tx-8-"man"-noun-0]|TX|3692/3|B01.050.150.900.649.801.400.112.400.400
00000000|MMI|25.70|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-5-"Instruction"-noun-0,"instructions"-tx-5-"Instructions"-noun-0,"instructions"-tx-4-"Instructions"-noun-0,"Instruction"-tx-3-"Instruction"-noun-0]|TX|[1283/11],[1873/11];[1804/12],[2469/12];1215/12;[509/11],[740/11]|
00000000|MMI|25.70|Instructions|C1442085|[idcn]|["Instructions"-tx-5-"Instructions"-noun-0,"instruction"-tx-5-"Instruction"-noun-0,"Instructions"-tx-4-"Instructions"-noun-0,"instruction"-tx-3-"Instruction"-noun-0]|TX|[1804/12],[2469/12];[1283/11],[1873/11];1215/12;[509/11],[740/11]|
00000000|MMI|25.50|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-5-"Instruction"-noun-0,"Instruction"-tx-3-"Instruction"-noun-0]|TX|[1283/11],[1873/11];[509/11],[740/11]|I02.903
00000000|MMI|25.31|Daunorubicin|C0011015|[antb,orch]|["DNR"-tx-20-"DNR"-noun-0]|TX|5051/3|D02.455.426.559.847.562.050.200;D04.615.562.050.200;D09.408.051.059.200
00000000|MMI|25.31|Sennosides|C3489575|[phsu]|["Sennosides"-tx-4-"SENNOSIDES"-noun-0]|TX|927/10|D02.455.426.559.847.117.159.750;D02.806.100.750;D20.215.784.500.860
00000000|MMI|24.92|Override|C1547671|[acty]|["Override"-tx-5-"Override"-verb-0,"Override"-tx-5-"overridden"-noun-0,"Override"-tx-5-"override"-verb-0]|TX|[1348/8],[1938/8];[1336/10],[1926/10];[1678/8],[2268/8]|
00000000|MMI|24.80|ECHO protocol|C0058928|[topp]|["ECHO"-tx-23-"ECHO"-noun-0,"ECHO"-tx-16-"Echo"-noun-0]|TX|5302/4;4698/4|x.x.x.x
00000000|MMI|24.78|Daily|C0332173|[tmco]|["Daily"-tx-21-"daily"-noun-0,"Daily"-tx-5-"daily"-adj-0,"QD"-tx-5-"QD"-noun-0,"QD"-tx-4-"QD"-noun-0,"QD"-tx-3-"QD"-noun-0]|TX|5195/5;2542/5;2362/2;1096/2;[389/2],[574/2],[608/2]|
00000000|MMI|24.49|ARID1A protein, human|C0675390|[aapp,bacs]|["hELD"-tx-18-"Held"-adj-0,"hELD"-tx-17-"held"-verb-0]|TX|4956/4;4802/4|x.x.x.x
00000000|MMI|24.40|Hyperkalemia|C0020461|[fndg]|["HYPERKALEMIA"-tx-18-"hyperkalemia"-noun-0,"Hyperkalemias"-tx-9-"hyperkalemic"-adj-0]|TX|4942/12;3887/12|C18.452.950.396
00000000|MMI|24.40|Macrophage Activation Syndrome|C1096155|[dsyn]|["MAS"-tx-22-"mass"-noun-0,"MAS"-tx-12-"mass"-noun-1]|TX|5281/4;4356/4|C20.683.515.800
00000000|MMI|24.33|ACE protein, human|C1452534|[aapp,bacs]|["ACE"-tx-18-"ACE"-noun-0,"ACE"-tx-15-"ACE"-noun-0]|TX|4961/3;4672/3|x.x.x.x
00000000|MMI|24.19|Allopurinol|C0002144|[orch,phsu]|["ALLOPURINOL"-tx-5-"ALLOPURINOL"-noun-0]|TX|[1400/11],[1990/11]|D03.438.759.160
00000000|MMI|24.17|Hospitalization|C0019993|[hlca]|["hospitalisation"-tx-19-"hospitalization"-noun-0,"Hospitalizations"-tx-8-"hospitalizations"-noun-0]|TX|5034/15;3767/16|E02.760.400;N02.421.585.400
00000000|MMI|22.91|To|C1883351|[qlco]|["To"-tx-22-"to"-adv-0,"To"-tx-21-"to"-noun-0,"To"-tx-7-"to"-adv-0,"To"-tx-5-"to"-adv-0]|TX|5265/2;5189/2;[2765/2],[2801/2],[2838/2];2420/2|
00000000|MMI|22.38|Digoxin|C0012265|[orch,phsu]|["DIGOXIN"-tx-8-"DIGOXIN"-noun-0]|TX|2993/7|D04.808.155.580.130.500.436;D04.808.155.580.130.688;D09.408.180.261.436
00000000|MMI|22.38|Insulin Glargine|C0907402|[aapp,horm,phsu]|["INSULIN GLARGINE"-tx-4-"INSULIN GLARGINE"-noun-0]|TX|1019/16|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|22.38|Surgical aspects|C0038895|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|3567/10|x.x.x.x.x.x.x
00000000|MMI|22.38|Walking (activity)|C0080331|[dora]|["Walking"-tx-5-"Walking"-noun-0]|TX|2648/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|21.60|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-13-"CHF"-noun-0,"CHF"-tx-8-"CHF"-noun-0,"CONGESTIVE HEART FAILURE"-tx-8-"congestive heart failure"-noun-0]|TX|4547/3;[3307/3],[3788/3];[3031/24],[3135/24],[3313/24]|
00000000|MMI|21.44|Peripheral Neuropathy|C0031117|[dsyn]|["PERIPHERAL NEUROPATHY"-tx-8-"Peripheral neuropathy"-noun-0,"PERIPHERAL NEUROPATHY"-tx-8-"peripheral neuropathy"-noun-0]|TX|3429/21;3453/21|C10.668.829
00000000|MMI|21.44|Peripheral Vascular Diseases|C0085096|[dsyn]|["PERIPHERAL VASCULAR DISEASE"-tx-8-"peripheral vascular disease"-noun-0,"pvd"-tx-8-"PVD"-noun-0]|TX|3503/27;3497/3|C14.907.617
00000000|MMI|20.97|20%|C3842589|[fndg]|["20%"-tx-5-"20"-integer-0,"20%"-tx-4-"20"-integer-0,"20%"-tx-1-"20"-fraction-0]|TX|[1774/2],[2352/2],[2408/2];[996/2],[1185/2];19/2|
00000000|MMI|20.94|Creatine Kinase MB Isoenzyme|C0010290|[aapp,enzy]|["CKMB"-tx-12-"CKMB"-noun-0]|TX|4406/4|D08.811.913.696.640.150.625
00000000|MMI|20.92|Matrix Metalloproteinases|C0623362|[aapp,enzy]|["MMP"-tx-8-"MMP"-noun-0]|TX|3696/3|D08.811.277.656.300.480.525;D08.811.277.656.675.374.525
00000000|MMI|20.91|Lantus|C0876064|[aapp,phsu]|["Lantus"-tx-4-"LANTUS"-noun-0]|TX|1010/6|D06.472.699.587.200.300.100;D12.644.548.586.200.300.100
00000000|MMI|20.91|Oxycontin|C0722364|[orch,phsu]|["OxyContin"-tx-4-"OXYCONTIN"-noun-0]|TX|953/9|D03.132.577.249.562.149.575;D03.549.686.607.204.650;D03.605.497.607.204.650;D04.615.723.795.576.149.575
00000000|MMI|20.87|Insulin Lispro|C0293359|[aapp,horm,phsu]|["INSULIN LISPRO"-tx-5-"INSULIN LISPRO"-noun-0]|TX|2451/14|D06.472.699.587.200.400.500;D12.644.548.586.200.400.500
00000000|MMI|20.80|Body Weight|C0005910|[orga]|["Weight"-tx-5-"weight"-noun-0]|TX|2535/6|C23.888.144;E01.370.600.115.100.160.120;E05.041.124.160.750;G07.100.100.160.120;G07.700.320.249.314.120
00000000|MMI|20.79|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-8-"Treatment"-noun-0]|TX|3228/9|x.x.x.x.x.x.x
00000000|MMI|19.45|Acid Ceramidase|C2350443|[aapp,enzy]|["AC"-tx-5-"AC"-noun-0]|TX|2483/2|D08.811.277.087.250.100
00000000|MMI|19.45|Docusate Sodium|C0243237|[orch,phsu]|["DOCUSATE SODIUM"-tx-3-"DOCUSATE SODIUM"-noun-0]|TX|425/15|D02.241.081.337.759.249
00000000|MMI|19.45|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-3-"FUROSEMIDE"-noun-0]|TX|585/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|18.83|Disease|C0012634|[dsyn]|["condition"-tx-22-"CONDITION"-noun-0,"condition"-tx-8-"Conditions"-noun-0]|TX|5220/9;3176/10|C23.550.288
00000000|MMI|18.60|Drawings (art)|C0013113|[inpr]|["Draw"-tx-7-"drawn"-verb-0]|TX|[2807/5],[2844/5]|V01.185.625;V02.700.300
00000000|MMI|18.50|Food|C0016452|[food]|["FOODS"-tx-5-"foods"-noun-0]|TX|[1324/5],[1914/5]|G07.203.300;J02.500
00000000|MMI|18.35|Ambulatory Care Facilities|C0002424|[hcro,mnob]|["Clinic"-tx-20-"clinic"-noun-0,"Clinic"-tx-6-"clinic"-noun-0]|TX|5165/6;2741/6|N02.278.035
00000000|MMI|17.98|Nicotinamide adenine dinucleotide (NAD)|C0027270|[bacs,nnon,phsu]|["NAD+"-tx-12-"NAD"-noun-0]|TX|4174/3|D03.438.759.646.138.694;D08.211.589;D13.695.667.138.694;D13.695.827.068.694
00000000|MMI|17.97|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-3-"meals"-noun-0]|TX|775/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|17.97|Colace|C0282139|[orch,phsu]|["Colace"-tx-3-"COLACE"-noun-0]|TX|416/6|D02.241.081.337.759.249
00000000|MMI|17.92|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|200/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|17.87|Creatine Kinase|C0010287|[aapp,enzy]|["CK"-tx-12-"CK"-noun-0]|TX|4399/2|D08.811.913.696.640.150
00000000|MMI|17.86|Vaccinia virus|C0042216|[virs]|["VV"-tx-8-"VV"-noun-0]|TX|3243/2|B04.280.650.160.650.900
00000000|MMI|17.82|Immunodeficiency Virus, Bovine|C0079031|[virs]|["BIV"-tx-8-"BiV"-noun-0]|TX|3750/3|B04.820.650.589.500.400
00000000|MMI|17.40|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-27-"DISCHARGE"-noun-0,"Discharge"-tx-22-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5425/9;5210/9;3066/9;344/9;40/9|
00000000|MMI|17.40|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-27-"DISCHARGE"-noun-0,"Discharge"-tx-22-"DISCHARGE"-noun-0,"Discharge"-tx-8-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-verb-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|5425/9;5210/9;3066/9;344/9;40/9|
00000000|MMI|17.40|Beginning|C0439659|[tmco]|["Start"-tx-20-"start"-verb-0,"Start"-tx-5-"Starting"-verb-0,"Start"-tx-4-"Starting"-adj-0,"Start"-tx-4-"Starting"-verb-0,"Start"-tx-3-"Starting"-adj-0]|TX|5098/5;1755/8;[824/8],[1166/8];[824/8],[1166/8];660/8|
00000000|MMI|16.52|Amlodipine|C0051696|[orch,phsu]|["AMLODIPINE"-tx-8-"AMLODIPINE"-noun-0]|TX|3003/10|D03.383.725.203.065
00000000|MMI|16.52|Antigua and Barbuda|C0003354|[geoa]|["AC"-tx-5-"AC"-noun-0]|TX|2483/2|Z01.107.084.900.050;Z01.639.880.050
00000000|MMI|16.52|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-8-"coronary artery disease"-noun-0]|TX|3281/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|16.52|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-8-"coronary artery disease"-noun-0]|TX|3281/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|16.52|Diabetes Mellitus, Insulin-Dependent|C0011854|[dsyn]|["IDDM"-tx-8-"IDDM"-noun-0]|TX|3402/4|C18.452.394.750.124;C19.246.267;C20.111.327
00000000|MMI|16.52|Dizziness|C0012833|[sosy]|["Dizzyness"-tx-10-"dizziness"-noun-1]|TX|3996/9|C10.597.751.237;C23.888.592.763.237
00000000|MMI|16.52|Folic Acid|C0016410|[orch,phsu,vita]|["FOLIC ACID"-tx-3-"FOLIC ACID"-noun-0]|TX|553/10|D03.438.733.631.400
00000000|MMI|16.52|Iodides|C0021966|[inch]|["I-"-tx-17-"I"-noun-0]|TX|4732/1|D01.248.497.158.490;D01.475.410
00000000|MMI|16.52|Left Bundle-Branch Block|C0023211|[dsyn]|["LBBB"-tx-12-"LBBB"-noun-1]|TX|4134/4|C14.280.067.558.323;C23.550.073.425.100
00000000|MMI|16.52|Meperidine Hydrochloride|C0353148|[orch,phsu]|["meperidine hcl"-tx-8-"MEPERIDINE HCL"-noun-0]|TX|2915/14|D03.066.399.450;D03.383.621.349.450
00000000|MMI|16.52|Metolazone|C0025854|[orch,phsu]|["METOLAZONE"-tx-3-"METOLAZONE"-noun-0]|TX|623/10|D02.065.884.600;D02.886.590.700.600;D03.438.786.830.688
00000000|MMI|16.52|Milk (body substance)|C0026131|[bdsu]|["MILK"-tx-3-"milk"-noun-0]|TX|527/4|A12.200.455;G07.203.100.700;G07.203.300.350.525;J02.200.700;J02.500.350.525
00000000|MMI|16.52|Nitrates|C0028125|[chvs]|["Nitrate"-tx-8-"NITRATE"-noun-0]|TX|2983/7|D01.248.497.158.606;D01.625.525.550;D02.583
00000000|MMI|16.52|Sildenafil citrate|C0724693|[orch,phsu]|["SILDENAFIL CITRATE"-tx-8-"SILDENAFIL CITRATE"-noun-0]|TX|2932/18|D02.065.884.675;D02.886.590.700.675;D03.383.606.854;D03.438.759.824
00000000|MMI|16.52|Spironolactone|C0037982|[orch,phsu]|["SPIRONOLACTONE"-tx-8-"SPIRONOLACTONE"-noun-0]|TX|2966/14|D02.540.679;D04.808.745.745.855
00000000|MMI|16.52|Vertigo|C0042571|[sosy]|["dizziness"-tx-10-"dizziness"-noun-1]|TX|3996/9|C09.218.568.900.883;C10.597.951;C23.888.592.958
00000000|MMI|15.20|Renal Insufficiency|C1565489|[dsyn]|["Renal dysfunction"-tx-8-"renal dysfunction"-noun-0]|TX|3547/17|C12.777.419.780;C13.351.968.419.780
00000000|MMI|15.17|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-5-"Low fat DIET"-noun-0]|TX|2596/3,2614/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|15.13|Central African Republic|C0007673|[geoa]|["CT"-tx-22-"CT"-noun-0]|TX|5262/2|Z01.058.290.100.120
00000000|MMI|15.13|Folate|C0178638|[orch,phsu,vita]|["Folate"-tx-3-"FOLATE"-noun-0]|TX|544/6|D03.438.733.631.400
00000000|MMI|15.06|isoniazid|C0022209|[orch,phsu]|["ISONIAZID"-tx-15-"inh"-noun-0]|TX|4676/3|D02.442.436;D03.066.349.410;D03.383.725.394.582
00000000|MMI|15.04|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-9-"lisinopril"-noun-0]|TX|3868/10|D12.644.456.345.600
00000000|MMI|14.96|Antacids|C0003138|[phsu]|["Antacid"-tx-3-"antacid"-noun-0]|TX|536/7|D27.505.519.170;D27.505.954.483.080
00000000|MMI|14.96|Anti-Ulcer Agent|C0003216|[phsu]|["Antacid"-tx-3-"antacid"-noun-0]|TX|536/7|D27.505.954.483.203
00000000|MMI|14.96|Diuretics|C0012798|[phsu]|["Diuretic"-tx-13-"diuretic"-adj-0]|TX|4586/8|D27.505.696.560.500
00000000|MMI|14.96|Potassium Chloride|C0032825|[inch,phsu]|["POTASSIUM CHLORIDE"-tx-5-"Potassium Chloride"-noun-0]|TX|2376/18|D01.210.450.150.750;D01.745.625
00000000|MMI|14.94|Fluorides|C0016327|[inch,phsu]|["F-"-tx-7-"f"-noun-0]|TX|2828/1|D01.248.497.158.380;D01.303.350.300
00000000|MMI|14.92|Diabetes Mellitus, Non-Insulin-Dependent|C0011860|[dsyn]|["MOD"-tx-16-"mod"-noun-0]|TX|4714/3|C18.452.394.750.149;C19.246.300
00000000|MMI|14.63|Schedule (document type)|C0086960|[inpr]|["Scheduled"-tx-23-"scheduled"-verb-0,"Schedule"-tx-7-"schedule"-verb-0,"Scheduled"-tx-6-"scheduled"-verb-0]|TX|5307/9;2768/8;2720/9|
00000000|MMI|14.63|Take|C1515187|[hlca]|["Take"-tx-5-"Take"-verb-0,"Take"-tx-4-"Take"-verb-0,"Take"-tx-3-"Take"-verb-0]|TX|1818/4;1229/4;752/4|
00000000|MMI|14.29|Integrated Neuromusculoskeletal Release|C1704538|[topp]|["INR"-tx-17-"INR"-noun-0,"INR"-tx-8-"INR's"-noun-0,"INR"-tx-7-"INR"-noun-0,"INR"-tx-7-"INR's"-noun-0]|TX|4821/3;2864/5;2797/3;2832/5|
00000000|MMI|13.61|23|C0450348|[qnco]|["23"-tx-27-"23"-fraction-0,"23"-tx-5-"23"-fraction-0,"23"-tx-1-"23"-fraction-0]|TX|5394/2;[1368/2],[1958/2];146/2|
00000000|MMI|13.60|Artificial cardiac pacemaker|C0030163|[medd]|["PACEMAKER"-tx-8-"pacemaker"-noun-0]|TX|3254/9|E07.305.250.750
00000000|MMI|13.60|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-8-"coronary artery disease"-noun-0]|TX|3281/23|C14.280.647.250;C14.907.585.250
00000000|MMI|13.60|Dyspnea|C0013404|[sosy]|["DYSPNOEA"-tx-8-"dyspnea"-noun-0]|TX|3837/7|C08.618.326;C23.888.852.371
00000000|MMI|13.60|Evaluation|C0220825|[hlca]|["Evaluate"-tx-22-"evaluate"-verb-0]|TX|5268/8|E05.337;N05.715.360.335
00000000|MMI|13.60|Fever|C0015967|[fndg]|["Fevers"-tx-10-"fevers"-noun-1]|TX|3956/6|C23.888.119.344
00000000|MMI|13.60|Needs|C0027552|[qlco]|["Needs"-tx-22-"Needs"-verb-0]|TX|5250/5|N03.349.380.420;N05.300.450
00000000|MMI|13.60|gabapentin|C0060926|[orch,phsu]|["GABAPENTIN"-tx-8-"GABAPENTIN"-noun-0]|TX|2953/10|x.x.x.x
00000000|MMI|13.60|sennosides, USP|C0074332|[orch,phsu]|["SENNOSIDES"-tx-4-"SENNOSIDES"-noun-0]|TX|927/10|x.x.x.x
00000000|MMI|13.31|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-27-"PM"-noun-0,"PM"-tx-18-"PM"-adj-0,"PM"-tx-8-"PM"-adj-0,"PM"-tx-1-"PM"-adj-0]|TX|5408/2;4889/2;3754/2;161/2|
00000000|MMI|13.25|HORNS IN SHEEP|C1832110|[fndg]|["HO"-tx-18-"ho"-noun-0,"HO"-tx-17-"ho"-noun-0,"HO"-tx-17-"ho"-noun-1,"HO"-tx-12-"ho"-noun-0]|TX|4899/2;[4741/2],[4769/2];[4741/2],[4769/2];4038/2|
00000000|MMI|13.25|Healthcare Encounters Domain|C3889614|[inpr]|["HO"-tx-18-"ho"-noun-0,"HO"-tx-17-"ho"-noun-0,"HO"-tx-12-"ho"-noun-0]|TX|4899/2;[4741/2],[4769/2];4038/2|
00000000|MMI|12.78|Body Fluids|C0005889|[bdsu]|["FLUID"-tx-14-"fluid"-noun-0,"FLUID"-tx-5-"fluid"-noun-0]|TX|4608/5;2445/5|A12.207
00000000|MMI|12.57|Patients|C0030705|[podg]|["*^patient"-tx-5-"Patient"-noun-0,"*^patient"-tx-5-"patient's"-noun-0]|TX|2512/7;2278/9|M01.643
00000000|MMI|12.29|Home visit (procedure)|C0020043|[hlca]|["home services"-tx-3-"Home services"-noun-0]|TX|327/4,335/8|N04.452.758.307
00000000|MMI|12.20|Cardiomegaly|C0018800|[fndg]|["CARDIOMEGALY"-tx-12-"cardiomegaly"-noun-1]|TX|4337/12|C14.280.195;C23.300.775.250
00000000|MMI|12.20|Chaplain|C0558269|[prog]|["Ch."-tx-2-"CH"-noun-0]|TX|287/2|M01.526.799.500
00000000|MMI|12.20|China|C0008115|[geoa]|["CH"-tx-2-"CH"-noun-0]|TX|287/2|Z01.252.474.164
00000000|MMI|12.20|Christmas Island|C0006888|[geoa]|["CXR"-tx-12-"CXR"-noun-0]|TX|4325/3|Z01.639.100;Z01.678.100.373
00000000|MMI|12.20|Cyclic neutropenia|C0221023|[dsyn]|["CH"-tx-2-"CH"-noun-0]|TX|287/2|x.x.x.x
00000000|MMI|12.14|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-22-"PLAN"-noun-0]|TX|5244/4|C10.228.140.744
00000000|MMI|12.10|Stomach|C0038351|[bpoc]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|793/7|A03.556.875.875
00000000|MMI|12.07|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|200/3|E04.157.310;E04.950.300.299
00000000|MMI|12.03|Chest|C0817096|[blor]|["CHEST"-tx-12-"chest"-noun-0]|TX|4216/5|A01.923.761;A02.835.232.904
00000000|MMI|12.00|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-5-"Sodium"-noun-0]|TX|2631/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|11.99|phosphoethanolamine|C0070939|[bacs,orch]|["PE"-tx-12-"PE"-noun-0]|TX|4280/2|x.x.x.x
00000000|MMI|11.99|ferrous sulfate|C0060282|[inch,phsu]|["Ferrous sulphate"-tx-3-"FERROUS SULFATE"-noun-0]|TX|457/15|x.x.x.x
00000000|MMI|11.98|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|118/3|J01.937.500.100
00000000|MMI|11.96|Symmetrical dyschromatosis of extremities|C0406775|[cgab,dsyn]|["RAD"-tx-12-"rad"-noun-0]|TX|4254/3|x.x.x.x
00000000|MMI|11.94|Direction|C0449738|[spco]|["Direction"-tx-5-"directed"-adj-0]|TX|2497/8|x.x.x.x
00000000|MMI|11.04|Hospital admission|C0184666|[hlca]|["Admit"-tx-12-"Admit"-verb-0,"Admission"-tx-8-"Admission"-noun-0,"Admit"-tx-8-"ADMIT"-verb-0]|TX|4074/5;3123/9;3014/5|
00000000|MMI|10.92|Order (action)|C1705178|[acty]|["Order"-tx-27-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5435/6;204/5;50/6|
00000000|MMI|10.92|Order (arrangement)|C1705176|[qlco]|["Order"-tx-27-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5435/6;204/5;50/6|
00000000|MMI|10.92|Order (document)|C1705175|[inpr]|["Order"-tx-27-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5435/6;204/5;50/6|
00000000|MMI|10.92|Order (taxonomic)|C1705177|[clas]|["Order"-tx-27-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5435/6;204/5;50/6|
00000000|MMI|10.92|Permutation|C1882348|[qlco]|["Order"-tx-27-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|5435/6;204/5;50/6|
00000000|MMI|10.92|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-27-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|5435/6;204/5;50/6|
00000000|MMI|10.67|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-5-"Instructions"-noun-0,"Instructions"-tx-4-"Instructions"-noun-0]|TX|[1804/12],[2469/12];1215/12|
00000000|MMI|10.67|Complication Aspects|C1171258|[patf]|["complications"-tx-8-"Complications"-noun-0]|TX|3202/13|x.x.x
00000000|MMI|10.67|Kidney|C0022646|[bpoc]|["Renal"-tx-18-"RENAL"-adj-0]|TX|4924/5|A05.810.453
00000000|MMI|10.67|Methods aspects|C0025664|[inpr]|["procedures"-tx-8-"PROCEDURES"-noun-0]|TX|3582/10|x.x.x
00000000|MMI|10.13|Today|C0310367|[antb,orch]|["Today"-tx-4-"Today"-noun-0,"Today"-tx-3-"Today"-noun-0]|TX|[833/5],[895/5];669/5|
00000000|MMI|10.13|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-4-"Today"-noun-0,"Today"-tx-3-"Today"-noun-0]|TX|[833/5],[895/5];669/5|
00000000|MMI|10.03|week|C0439230|[tmco]|["WEEKS"-tx-8-"weeks"-noun-0,"WEEKS"-tx-7-"weeks"-noun-0,"WEEK"-tx-3-"Week"-noun-0]|TX|3821/5;2781/5;649/4|
00000000|MMI|10.02|Basal Diet|C2983588|[food]|["DIET"-tx-5-"DIET"-noun-0]|TX|[2506/4],[2548/4],[2582/4]|
00000000|MMI|10.02|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-5-"DIET"-noun-0]|TX|[2506/4],[2548/4],[2582/4]|
00000000|MMI|10.02|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-5-"DIET"-noun-0]|TX|[2506/4],[2548/4],[2582/4]|
00000000|MMI|9.96|R prime|C2603358|[clna]|["R'"-tx-17-"R"-noun-0,"R'"-tx-12-"R"-adj-0,"R'"-tx-8-"R"-noun-0]|TX|4766/1;4288/1;3638/1|
00000000|MMI|9.96|Right|C0205090|[spco]|["R-"-tx-17-"R"-noun-0,"R-"-tx-12-"R"-adj-0,"R-"-tx-8-"R"-noun-0]|TX|4766/1;4288/1;3638/1|
00000000|MMI|9.92|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-22-"Stable"-adj-0,"Stable"-tx-19-"stable"-adj-0,"Stable"-tx-12-"stable"-adj-0]|TX|5231/6;5016/6;4330/6|
00000000|MMI|9.92|Stable status|C0205360|[qlco]|["STABLE"-tx-22-"Stable"-adj-0,"STABLE"-tx-19-"stable"-adj-0,"STABLE"-tx-12-"stable"-adj-0]|TX|5231/6;5016/6;4330/6|
00000000|MMI|9.88|Regimen - CHV concept|C2945654|[inpr]|["regimen"-tx-13-"regimen"-noun-0,"regimen"-tx-5-"regimen"-noun-0]|TX|4595/7;[1703/7],[2293/7]|
00000000|MMI|9.86|Once a day, at bedtime|C1275563|[tmco]|["qHS"-tx-5-"QHS"-noun-0,"qHS"-tx-4-"QHS"-noun-0]|TX|2490/3;[949/3],[1050/3]|
00000000|MMI|9.79|+2|C0740116|[qnco]|["+2"-tx-5-"2"-integer-0,"+2"-tx-4-"2"-integer-0]|TX|[2573/1],[2624/1];940/1|
00000000|MMI|9.79|2+|C3833492|[fndg]|["2+"-tx-5-"2"-integer-0,"2+"-tx-4-"2"-integer-0]|TX|[2573/1],[2624/1];940/1|
00000000|MMI|9.79|2+ Score|C2827735|[qnco]|["2+"-tx-5-"2"-integer-0,"2+"-tx-4-"2"-integer-0]|TX|[2573/1],[2624/1];940/1|
00000000|MMI|9.79|2+ Score, WHO|C2981700|[clas]|["2+"-tx-5-"2"-integer-0,"2+"-tx-4-"2"-integer-0]|TX|[2573/1],[2624/1];940/1|
00000000|MMI|9.72|70%|C3842584|[fndg]|["70%"-tx-13-"70"-integer-0,"70%"-tx-12-"70"-fraction-1,"70%"-tx-8-"70"-integer-0]|TX|4512/2;4156/2;3686/2|
00000000|MMI|9.67|Alert|C3665546|[ftcn]|["Alert"-tx-5-"Alert"-verb-0]|TX|[1330/5],[1920/5]|
00000000|MMI|9.67|Alert:Type:Point in time:^Patient:Nominal|C3669039|[clna]|["Alert"-tx-5-"Alert"-verb-0]|TX|[1330/5],[1920/5]|
00000000|MMI|9.67|Atrial Fibrillation by ECG Finding|C0344434|[lbtr]|["AFib"-tx-8-"Afib"-noun-0,"Atrial Fibrillation"-tx-8-"atrial fibrillation"-noun-0]|TX|3340/4;3347/19|
00000000|MMI|9.67|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-8-"CRI"-noun-0]|TX|[3533/3],[3738/3]|
00000000|MMI|9.67|Consciousness clear|C0239110|[fndg]|["ALERT"-tx-5-"Alert"-verb-1]|TX|[1330/5],[1920/5]|
00000000|MMI|9.67|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-8-"CRI"-noun-0]|TX|[3533/3],[3738/3]|
00000000|MMI|9.67|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|2750/2;2697/2|
00000000|MMI|9.67|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-6-"Dr"-noun-0,"DR"-tx-5-"Dr"-noun-0]|TX|2750/2;2697/2|
00000000|MMI|9.67|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0]|TX|[3020/9],[3166/9]|E01
00000000|MMI|9.67|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-8-"DIAGNOSIS"-noun-0]|TX|[3020/9],[3166/9]|
00000000|MMI|9.67|Doctor - Title|C2348314|[cnce]|["Dr."-tx-6-"Dr"-noun-0,"Dr."-tx-5-"Dr"-noun-0]|TX|2750/2;2697/2|
00000000|MMI|9.67|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-25-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|5369/3;278/3|
00000000|MMI|9.67|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-8-"Obesity"-noun-0,"Obesity"-tx-8-"obesity"-noun-0]|TX|3477/7;3487/7|
00000000|MMI|9.67|RNH1 gene|C1826843|[gngm]|["CRI"-tx-8-"CRI"-noun-0]|TX|[3533/3],[3738/3]|
00000000|MMI|9.67|Scheduled - priority|C1571999|[qlco]|["Scheduled"-tx-23-"scheduled"-verb-0,"Scheduled"-tx-6-"scheduled"-verb-0]|TX|5307/9;2720/9|
00000000|MMI|9.67|Scheduled - procedure status|C0205539|[qlco]|["Scheduled"-tx-23-"scheduled"-verb-0,"Scheduled"-tx-6-"scheduled"-verb-0]|TX|5307/9;2720/9|
00000000|MMI|9.67|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-27-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|5435/6;50/6|
00000000|MMI|9.27|Neurology speciality|C0027855|[bmod]|["NEURO"-tx-18-"NEURO"-adj-0]|TX|4892/5|H02.403.600
00000000|MMI|9.23|Appointments|C0003629|[idcn]|["Appointment"-tx-5-"APPOINTMENT"-noun-0]|TX|2679/11|N04.452.095
00000000|MMI|9.11|Outpatients|C0029921|[podg]|["Outpatient"-tx-23-"outpatient"-noun-0]|TX|5291/10|M01.643.630
00000000|MMI|9.08|Cocos (Keeling) Islands|C0009212|[geoa]|["CK"-tx-12-"CK"-noun-0]|TX|4399/2|Z01.639.520
00000000|MMI|9.07|Males|C0086582|[orga]|["MAN"-tx-8-"man"-noun-0]|TX|3692/3|x.x.x
00000000|MMI|9.07|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-4-"TAB"-noun-0]|TX|942/3|D26.255.830
00000000|MMI|9.06|Colchicine|C0009262|[orch,phsu]|["COLCHICINE"-tx-3-"COLCHICINE"-noun-0]|TX|392/10|D03.132.225
00000000|MMI|9.03|Back|C0004600|[blor]|["BACK"-tx-14-"back"-adj-0]|TX|4626/4|A01.923.176
00000000|MMI|7.74|Electrolytes|C0013832|[inch,phsu]|["ELECTROLYTES"-tx-19-"electrolytes"-noun-0]|TX|5003/12|D01.248
00000000|MMI|7.74|Infection|C3714514|[patf]|["Infections"-tx-8-"Infections"-noun-0]|TX|3189/10|C01.539
00000000|MMI|7.74|Measures|C0079809|[qnco]|["Measure"-tx-5-"measure"-verb-0]|TX|2527/7|E05.978
00000000|MMI|7.14|Echo (insect)|C1655045|[euka]|["Echo"-tx-23-"ECHO"-noun-0,"Echo"-tx-16-"Echo"-noun-0]|TX|5302/4;4698/4|
00000000|MMI|7.06|Condition|C0348080|[qlco]|["Condition"-tx-22-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|5220/9;3176/10|
00000000|MMI|7.06|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-22-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|5220/9;3176/10|
00000000|MMI|7.06|Logical Condition|C1705253|[cnce]|["Condition"-tx-22-"CONDITION"-noun-0,"Condition"-tx-8-"Conditions"-noun-0]|TX|5220/9;3176/10|
00000000|MMI|7.05|Standard Time|C3641800|[tmco]|["Standard Time"-tx-5-"Standard Time"-noun-0,"Standard Time"-tx-4-"Standard Time"-noun-0]|TX|1782/8,1797/4;1193/8,1208/4|
00000000|MMI|6.89|Entity Name Part Type - given|C1550718|[idcn]|["given"-tx-12-"given"-verb-0,"given"-tx-5-"given"-verb-0]|TX|4439/5;2426/5|
00000000|MMI|6.89|Fluid behavior|C0444611|[qlco]|["Fluid"-tx-14-"fluid"-noun-0,"Fluid"-tx-5-"fluid"-noun-0]|TX|4608/5;2445/5|
00000000|MMI|6.89|GIVEN|C1442162|[cnce]|["GIVEN"-tx-12-"given"-verb-0,"GIVEN"-tx-5-"given"-verb-0]|TX|4439/5;2426/5|
00000000|MMI|6.89|Give - dosing instruction imperative|C1947971|[ftcn]|["Given"-tx-12-"given"-verb-0,"Given"-tx-5-"given"-verb-0]|TX|4439/5;2426/5|
00000000|MMI|6.89|Given name|C3244317|[inpr]|["given"-tx-12-"given"-verb-0,"given"-tx-5-"given"-verb-0]|TX|4439/5;2426/5|
00000000|MMI|6.89|Liquid substance|C0302908|[sbst]|["fluid"-tx-14-"fluid"-noun-0,"fluid"-tx-5-"fluid"-noun-0]|TX|4608/5;2445/5|
00000000|MMI|6.89|fluid - substance|C1704353|[sbst]|["Fluid"-tx-14-"fluid"-noun-0,"Fluid"-tx-5-"fluid"-noun-0]|TX|4608/5;2445/5|
00000000|MMI|6.89|Discontinued|C1444662|[fndg]|["Discontinued"-tx-15-"discontinued"-verb-0,"D/C"-tx-1-"D/C"-noun-1]|TX|4684/12;200/3|
00000000|MMI|6.87|Cancer/Testis Antigen|C3813556|[aapp]|["CT"-tx-22-"CT"-noun-0,"CTA"-tx-12-"CTA"-noun-0]|TX|5262/2;4222/3|
00000000|MMI|6.87|PCYT1A wt Allele|C3540513|[gngm]|["CT"-tx-22-"CT"-noun-0,"CTA"-tx-12-"CTA"-noun-0]|TX|5262/2;4222/3|
00000000|MMI|6.87|Respiratory Domain|C2986904|[idcn]|["RE"-tx-20-"re"-verb-0,"RE"-tx-17-"re"-verb-0]|TX|5095/2;4837/2|
00000000|MMI|6.87|Retinol equivalents|C0556581|[qnco]|["{RE}"-tx-20-"re"-verb-0,"{RE}"-tx-17-"re"-verb-0]|TX|5095/2;4837/2|
00000000|MMI|6.87|Routine|C0205547|[qlco]|["Routine"-tx-5-"ROUTINE"-adj-0,"Routine"-tx-4-"ROUTINE"-adj-0]|TX|1764/7;1175/7|
00000000|MMI|6.83|ARID1A wt Allele|C2985160|[gngm]|["hELD"-tx-18-"Held"-adj-0,"hELD"-tx-17-"held"-verb-0]|TX|4956/4;4802/4|
00000000|MMI|6.83|Held - activity status|C1948036|[idcn]|["held"-tx-18-"Held"-adj-0,"held"-tx-17-"held"-verb-0]|TX|4956/4;4802/4|
00000000|MMI|6.74|Mass of body region|C0577573|[sosy]|["Mass"-tx-22-"mass"-noun-0,"Mass"-tx-12-"mass"-noun-1]|TX|5281/4;4356/4|
00000000|MMI|6.74|Mass of body structure|C0577559|[fndg]|["MASS"-tx-22-"mass"-noun-0,"MASS"-tx-12-"mass"-noun-1]|TX|5281/4;4356/4|
00000000|MMI|6.74|Mass, a measure of quantity of matter|C1306372|[qnco]|["*Mass"-tx-22-"mass"-noun-0,"*Mass"-tx-12-"mass"-noun-0]|TX|5281/4;4356/4|
00000000|MMI|6.74|Milliampere second|C3539882|[qnco]|["mAs"-tx-22-"mass"-noun-0,"mAs"-tx-12-"mass"-noun-0]|TX|5281/4;4356/4|
00000000|MMI|6.74|Molecular Mass|C3152252|[qnco]|["Mass"-tx-22-"mass"-noun-0,"Mass"-tx-12-"mass"-noun-0]|TX|5281/4;4356/4|
00000000|MMI|6.73|Every evening|C0585330|[tmco]|["QPM"-tx-5-"QPM"-noun-0,"QPM"-tx-4-"QPM"-noun-0]|TX|1751/3;1162/3|
00000000|MMI|6.73|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-5-"QPM"-noun-0,"qPM"-tx-4-"QPM"-noun-0]|TX|1751/3;1162/3|
00000000|MMI|6.73|Summary (document)|C1706244|[inpr]|["Summary"-tx-24-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|5330/7;229/7|
00000000|MMI|6.73|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-24-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|5330/7;229/7|
00000000|MMI|6.72|cisplatin/cyclophosphamide/doxorubicin/etoposide|C4048252|[phsu]|["PACE"-tx-17-"paced"-noun-0,"PACE"-tx-12-"paced"-noun-0]|TX|4782/5;4126/5|
00000000|MMI|6.72|pace - unit of measure|C1552930|[qnco]|["Pace"-tx-17-"paced"-noun-0,"Pace"-tx-12-"paced"-noun-0]|TX|4782/5;4126/5|
00000000|MMI|6.71|Laboratory test finding|C0587081|[fndg]|["Labs"-tx-12-"Labs"-noun-0,"Labs"-tx-12-"labs"-noun-1]|TX|4080/4;4368/4|
00000000|MMI|6.70|Indication of (contextual qualifier)|C0392360|[idcn]|["Reason"-tx-5-"Reason"-noun-0]|TX|[1667/6],[2257/6]|
00000000|MMI|6.69|+5|C0728893|[qnco]|["+5"-tx-27-"5"-fraction-0,"+5"-tx-1-"5"-fraction-0]|TX|5392/1;144/1|
00000000|MMI|6.69|>5|C0439084|[qnco]|[">5"-tx-27-"5"-fraction-0,">5"-tx-1-"5"-fraction-0]|TX|5392/1;144/1|
00000000|MMI|6.69|Dosage|C0178602|[qnco]|["DOSE"-tx-17-"dose"-noun-0,"DOSE"-tx-5-"dose"-noun-0]|TX|4853/4;2415/4|
00000000|MMI|6.69|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose #"-tx-17-"dose"-noun-0,"Dose #"-tx-5-"dose"-noun-0]|TX|4853/4;2415/4|
00000000|MMI|6.69|FABP6 protein, human|C1435727|[aapp,bacs]|["GT"-tx-17-"gt"-noun-0,"GT"-tx-12-"gt"-noun-0]|TX|4825/2;4285/2|
00000000|MMI|6.69|Recent|C0332185|[tmco]|["Recent"-tx-13-"recent"-adj-0,"Recently"-tx-9-"Recently"-adv-0]|TX|4569/6;3846/8|
00000000|MMI|6.69|TDGF1P4 gene|C3469969|[gngm]|["CR-4"-tx-12-"Cr 4"-noun-0,"CR-4"-tx-12-"cr 4"-noun-0]|TX|4086/2,4091/1;4374/2,4379/1|
00000000|MMI|6.69|Unit dose|C0869039|[qnco]|["Dose"-tx-17-"dose"-noun-0,"Dose"-tx-5-"dose"-noun-0]|TX|4853/4;2415/4|
00000000|MMI|6.68|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-5-"Patient"-noun-0,"Patient"-tx-5-"patient's"-noun-0]|TX|2512/7;2278/9|
00000000|MMI|6.68|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-5-"Patient"-noun-0,"Patient"-tx-5-"patient's"-noun-0]|TX|2512/7;2278/9|
00000000|MMI|6.68|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-5-"Patient"-noun-0,"Patient"-tx-5-"patient's"-noun-0]|TX|2512/7;2278/9|
00000000|MMI|6.64|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-20-"follow-up"-adj-0,"FOLLOW-UP"-tx-5-"FOLLOW UP"-adj-0]|TX|5137/9;2669/9|
00000000|MMI|6.64|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-20-"follow-up"-adj-0,"Follow-Up"-tx-5-"FOLLOW UP"-adj-0]|TX|5137/9;2669/9|
00000000|MMI|6.64|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-20-"follow-up"-adj-1,"Follow-up"-tx-5-"FOLLOW UP"-adj-0]|TX|5137/9;2669/9|
00000000|MMI|6.64|follow-up|C1522577|[hlca]|["Follow Up"-tx-20-"follow-up"-adj-0,"Follow Up"-tx-5-"FOLLOW UP"-adj-0]|TX|5137/9;2669/9|
00000000|MMI|6.64|Additional|C1524062|[ftcn]|["Added"-tx-5-"added"-verb-0]|TX|[1357/5],[1947/5]|
00000000|MMI|6.60|Weight|C0043100|[qnco]|["WEIGHTS"-tx-21-"weights"-noun-0,"WEIGHT"-tx-5-"weight"-noun-0]|TX|5201/7;2535/6|
00000000|MMI|6.59|Out (direction)|C0439787|[spco]|["Out"-tx-17-"out"-adv-0,"Out"-tx-12-"out"-adv-0]|TX|4755/3;4463/3|
00000000|MMI|6.59|Removed|C0849355|[qlco]|["Out"-tx-17-"out"-adv-0,"Out"-tx-12-"out"-adv-0]|TX|4755/3;4463/3|
00000000|MMI|6.58|Clinic|C0442592|[hcro,mnob]|["Clinic"-tx-20-"clinic"-noun-0,"Clinic"-tx-6-"clinic"-noun-0]|TX|5165/6;2741/6|
00000000|MMI|6.55|Negation|C1518422|[ftcn]|["Not"-tx-20-"not"-adv-0,"Not"-tx-8-"NOT"-adv-0]|TX|5055/3;3629/3|
00000000|MMI|6.54|FBL gene|C1414538|[gngm]|["FIB"-tx-17-"fib"-noun-0,"FIB"-tx-8-"fib"-noun-0]|TX|4774/3;3746/3|
00000000|MMI|6.51|Code|C0805701|[inpr]|["CODE"-tx-3-"CODE"-noun-0,"CODE"-tx-3-"code"-noun-0]|TX|291/4;309/4|
00000000|MMI|6.51|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-3-"CODE"-noun-0,"Code"-tx-3-"code"-noun-0]|TX|291/4;309/4|
00000000|MMI|6.50|Vitamin K Drug Class|C3714648|[phsu,vita]|["VITAMIN K"-tx-5-"Vitamin-K"-noun-0]|TX|[1303/9],[1893/9]|
00000000|MMI|6.50|Vitamin K [EPC]|C2936884|[phsu]|["Vitamin K"-tx-5-"Vitamin-K"-noun-0]|TX|[1303/9],[1893/9]|
00000000|MMI|6.50|Vitamin K containing hemostatics|C3541380|[orch,phsu,vita]|["Vitamin K"-tx-5-"Vitamin-K"-noun-0]|TX|[1303/9],[1893/9]|
00000000|MMI|6.50|Discharge to home|C0184713|[topp]|["Discharge home"-tx-17-"home discharge"-noun-0,"Release home"-tx-5-"home RELEASE"-noun-0]|TX|4848/4,4878/9;2288/4,2344/7|
00000000|MMI|6.46|Structure of right upper lobe of lung|C1261074|[bpoc]|["RUL"-tx-22-"RUL"-noun-0,"RUL"-tx-12-"RUL"-noun-0]|TX|5277/3;4364/3|
00000000|MMI|6.46|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-8-"CAD"-adj-0]|TX|[3266/3],[3723/3]|
00000000|MMI|6.46|Abnormally high|C1299351|[qlco]|["High"-tx-5-"high"-adj-0]|TX|[1298/4],[1888/4]|
00000000|MMI|6.46|Contain (action)|C2700400|[acty]|["Containing"-tx-5-"containing"-adj-0]|TX|[1313/10],[1903/10]|
00000000|MMI|6.46|Containing (qualifier)|C0332256|[ftcn]|["Containing"-tx-5-"containing"-adj-0]|TX|[1313/10],[1903/10]|
00000000|MMI|6.46|High|C0205250|[qlco]|["High"-tx-5-"high"-adj-0]|TX|[1298/4],[1888/4]|
00000000|MMI|6.46|High Mitosis-Karyorrhexis Index|C3889660|[qnco]|["High"-tx-5-"high"-adj-0]|TX|[1298/4],[1888/4]|
00000000|MMI|6.46|Value Above Reference Range|C2700149|[inpr]|["HIGH"-tx-5-"high"-adj-0]|TX|[1298/4],[1888/4]|
00000000|MMI|6.46|high - ActExposureLevelCode|C3887512|[idcn]|["high"-tx-5-"high"-adj-0]|TX|[1298/4],[1888/4]|
00000000|MMI|6.45|Patient's home|C3698592|[mnob]|["Patient's home"-tx-5-"patient's home"-noun-0]|TX|[1688/14],[2278/14]|
00000000|MMI|6.45|Numerous|C0439064|[qnco]|["MULTIPLE"-tx-13-"multiple"-adj-0,"MULTIPLE"-tx-8-"multiple"-adj-0]|TX|4479/8;3758/8|
00000000|MMI|6.44|Three times daily|C0556984|[tmco]|["TID"-tx-4-"TID"-noun-0,"TID"-tx-3-"TID"-noun-0]|TX|882/3;483/3|
00000000|MMI|6.44|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-4-"TID"-noun-0,"TID"-tx-3-"TID"-noun-0]|TX|882/3;483/3|
00000000|MMI|6.43|mEq|C0439152|[qnco]|["mEq"-tx-5-"MEQ"-noun-0,"mEq"-tx-5-"mEq"-noun-0]|TX|2355/3;2411/3|
00000000|MMI|6.42|CDR2 gene|C1413296|[gngm]|["Yo"-tx-13-"Yo"-noun-0,"Yo"-tx-8-"yo"-noun-0]|TX|4515/2;3689/2|
00000000|MMI|6.28|Policy|C0242456|[inpr]|["Policy"-tx-5-"Policy"-noun-0]|TX|2395/6|I01.655;N03.623
00000000|MMI|6.27|Signs and Symptoms|C0037088|[sosy]|["Finding"-tx-12-"finding"-noun-0]|TX|4184/7|C23.888
00000000|MMI|6.14|Male population group|C0025266|[popg]|["Man"-tx-8-"man"-noun-0]|TX|3692/3|M01.390
00000000|MMI|4.81|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-17-"3"-integer-0]|TX|4828/1|
00000000|MMI|4.81|3+ Score|C2827736|[qnco]|["3+"-tx-17-"3"-integer-0]|TX|4828/1|
00000000|MMI|4.81|3+ Score, WHO|C2981702|[clas]|["3+"-tx-17-"3"-integer-0]|TX|4828/1|
00000000|MMI|4.81|7 days|C1547085|[tmco]|["7 days"-tx-7-"7 days"-noun-0]|TX|2856/6|
00000000|MMI|4.81|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-17-"3"-integer-0]|TX|4828/1|
00000000|MMI|4.81|ASAH1 gene|C1412573|[gngm]|["AC"-tx-5-"AC"-noun-0]|TX|2483/2|
00000000|MMI|4.81|ASAH1 wt Allele|C3539770|[gngm]|["AC"-tx-5-"AC"-noun-0]|TX|2483/2|
00000000|MMI|4.81|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|3567/10|
00000000|MMI|4.81|Affecting|C0392760|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|3218/9|
00000000|MMI|4.81|Atrial Fibrillation Adverse Event|C1963067|[fndg]|["Atrial fibrillation"-tx-8-"atrial fibrillation"-noun-0]|TX|3347/19|
00000000|MMI|4.81|Blood group antibody I|C0221138|[aapp,imft]|["I NOS"-tx-17-"I"-noun-0]|TX|4732/1|
00000000|MMI|4.81|CR2 wt Allele|C3539604|[gngm]|["CR"-tx-19-"Cr"-noun-0]|TX|4996/2|
00000000|MMI|4.81|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-7-"call"-verb-0]|TX|2760/4|
00000000|MMI|4.81|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-14-"CV"-noun-0]|TX|4604/2|
00000000|MMI|4.81|Clipperton Island|C4050020|[geoa]|["CP"-tx-10-"CP"-noun-0]|TX|3951/2|
00000000|MMI|4.81|Complication|C0009566|[patf]|["Complications"-tx-8-"Complications"-noun-0]|TX|3202/13|
00000000|MMI|4.81|Continuous|C0549178|[idcn]|["Continue"-tx-21-"continue"-verb-0]|TX|5180/8|
00000000|MMI|4.81|Controlled Release Dosage Form|C1707506|[bodm]|["Controlled Release"-tx-4-"CONTROLLED RELEASE"-adj-0]|TX|975/18|
00000000|MMI|4.81|Controlled release|C0868939|[tmco]|["Controlled release"-tx-4-"CONTROLLED RELEASE"-adj-0]|TX|975/18|
00000000|MMI|4.81|Cow's milk|C0349374|[food]|["Milk"-tx-3-"milk"-noun-0]|TX|527/4|
00000000|MMI|4.81|Creatinine measurement|C0201975|[lbpr]|["Cr"-tx-19-"Cr"-noun-0]|TX|4996/2|
00000000|MMI|4.81|DNR - Do not resuscitate|C0582114|[fndg]|["DNR"-tx-20-"DNR"-noun-0]|TX|5051/3|
00000000|MMI|4.81|Dario|C1470250|[fish]|["Dario"-tx-7-"Dario"-noun-0]|TX|2754/5|
00000000|MMI|4.81|Decision|C0679006|[menp]|["Call"-tx-7-"call"-verb-0]|TX|2760/4|
00000000|MMI|4.81|Decreased|C0205216|[qnco]|["Decreased"-tx-9-"decreased"-verb-0]|TX|3926/9|
00000000|MMI|4.81|Decreasing|C0442797|[qlco]|["decreased"-tx-9-"decreased"-verb-0]|TX|3926/9|
00000000|MMI|4.81|Denied (qualifier)|C0332319|[qlco]|["Denied"-tx-10-"denied"-verb-0]|TX|3940/6|
00000000|MMI|4.81|Deny (action)|C2700401|[acty]|["Denied"-tx-10-"denied"-verb-0]|TX|3940/6|
00000000|MMI|4.81|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-18-"diabetes"-noun-0]|TX|4931/8|
00000000|MMI|4.81|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.81|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|4.81|Dizziness Adverse Event|C1963093|[fndg]|["Dizziness"-tx-10-"dizziness"-noun-1]|TX|3996/9|
00000000|MMI|4.81|Doctor of Philosophy|C1512022|[inpr]|["Ph.D."-tx-26-"PH.D"-noun-0]|TX|5376/4|
00000000|MMI|4.81|Electrocardiogram: left bundle branch block (finding)|C0344420|[lbtr]|["LBBB"-tx-12-"LBBB"-noun-1]|TX|4134/4|
00000000|MMI|4.81|Electrolyte [EPC]|C3536863|[phsu]|["Electrolytes"-tx-19-"electrolytes"-noun-0]|TX|5003/12|
00000000|MMI|4.81|Endocrine System Findings Domain|C3538926|[idcn]|["ED"-tx-12-"ED"-noun-0]|TX|4436/2|
00000000|MMI|4.81|Evening|C0587117|[tmco]|["Evening"-tx-20-"evening"-noun-0]|TX|5123/7|
00000000|MMI|4.81|Fluid restriction|C0204700|[topp]|["Fluid restriction"-tx-5-"Fluid restriction"-noun-0]|TX|2554/17|
00000000|MMI|4.81|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-8-"OPERATIONS"-noun-0]|TX|3567/10|
00000000|MMI|4.81|Including (qualifier)|C0332257|[ftcn]|["Including"-tx-8-"including"-verb-0]|TX|3700/9|
00000000|MMI|4.81|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-8-"PROCEDURES"-noun-0]|TX|3582/10|
00000000|MMI|4.81|Involvement with|C1314939|[ftcn]|["Affecting"-tx-8-"affecting"-verb-0]|TX|3218/9|
00000000|MMI|4.81|Measurement|C0242485|[ftcn]|["Measure"-tx-5-"measure"-verb-0]|TX|2527/7|
00000000|MMI|4.81|Medical History|C0262926|[fndg]|["PMH"-tx-12-"PMH"-noun-0]|TX|4023/3|
00000000|MMI|4.81|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|354/11|
00000000|MMI|4.81|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|354/11|
00000000|MMI|4.81|Mild (qualifier value)|C2945599|[qlco]|["MILD"-tx-16-"mild"-adj-0]|TX|4723/4|
00000000|MMI|4.81|Milk - dietary|C2825079|[food]|["MILK"-tx-3-"milk"-noun-0]|TX|527/4|
00000000|MMI|4.81|Milk Specimen|C0444318|[sbst]|["Milk"-tx-3-"milk"-noun-0]|TX|527/4|
00000000|MMI|4.81|Nitrate|C0699857|[inch]|["Nitrate"-tx-8-"NITRATE"-noun-0]|TX|2983/7|
00000000|MMI|4.81|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|180/14|
00000000|MMI|4.81|Pacemaker ECG Assessment|C3853703|[diap]|["Pacemaker"-tx-8-"pacemaker"-noun-0]|TX|3254/9|
00000000|MMI|4.81|Pacemaker Procedure|C3275122|[topp]|["PACEMAKER"-tx-8-"pacemaker"-noun-0]|TX|3254/9|
00000000|MMI|4.81|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|180/14|
00000000|MMI|4.81|Palpitations|C0030252|[fndg]|["PALPITATIONS"-tx-10-"palpitations"-noun-1]|TX|3965/12|
00000000|MMI|4.81|Palpitations Adverse Event|C3160712|[fndg]|["Palpitations"-tx-10-"palpitations"-noun-1]|TX|3965/12|
00000000|MMI|4.81|Patient Outcome - Worsening|C1546960|[idcn]|["Worsening"-tx-8-"worsening"-verb-0]|TX|3827/9|
00000000|MMI|4.81|Patient need for (contextual qualifier)|C0686904|[ftcn]|["needs"-tx-22-"Needs"-verb-0]|TX|5250/5|
00000000|MMI|4.81|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-3-"MEDICATIONS"-noun-0]|TX|354/11|D26
00000000|MMI|4.81|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-10-"Pt"-noun-0]|TX|3937/2|
00000000|MMI|4.81|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-10-"Pt"-noun-0]|TX|3937/2|
00000000|MMI|4.81|Positive|C1446409|[qlco]|["ruled"-tx-17-"ruled"-verb-0]|TX|4749/5|
00000000|MMI|4.81|Present|C0150312|[qnco]|["Present"-tx-8-"presents"-verb-0]|TX|3806/8|
00000000|MMI|4.81|Presentation|C0449450|[idcn]|["Present"-tx-8-"presents"-verb-0]|TX|3806/8|
00000000|MMI|4.81|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-8-"PROCEDURES"-noun-0]|TX|3582/10|
00000000|MMI|4.81|Reduced|C0392756|[qlco]|["Decreased"-tx-9-"decreased"-verb-0]|TX|3926/9|
00000000|MMI|4.81|S prime|C2603362|[clna]|["S'"-tx-5-"("-noun-0]|TX|2690/1|
00000000|MMI|4.81|Specimen Source Codes - Pacemaker|C1546728|[inpr]|["Pacemaker"-tx-8-"pacemaker"-noun-0]|TX|3254/9|
00000000|MMI|4.81|Then|C1883708|[tmco]|["Then"-tx-17-"then"-adv-0]|TX|4832/4|
00000000|MMI|4.81|Worse|C1457868|[fndg]|["Worsening"-tx-8-"worsening"-verb-0]|TX|3827/9|
00000000|MMI|4.81|Worsening pattern|C0332271|[qlco]|["Worsening"-tx-8-"worsening"-verb-0]|TX|3827/9|
00000000|MMI|4.81|per second|C0565930|[qnco]|["/s"-tx-5-"("-noun-0]|TX|2690/1|
00000000|MMI|4.81|put - instruction imperative|C1882509|[acty]|["Put"-tx-12-"put"-verb-0]|TX|4459/3|
00000000|MMI|4.81|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-8-"TREATMENTS/PROCEDURES"-noun-0]|TX|3605/21|
00000000|MMI|3.73|Senokot Tablets|C1616946|[clnd]|["Senokot Tablets"-tx-4-"SENNA TABLETS"-noun-0]|TX|911/13|
00000000|MMI|3.51|Known Coronary Artery Disease|C3275096|[qnco]|["KNOWN CAD"-tx-17-"known CAD"-noun-0]|TX|4735/5,4744/3|
00000000|MMI|3.48|Renal dysfunction|C3279454|[fndg]|["Renal dysfunction"-tx-8-"renal dysfunction"-noun-0]|TX|3547/17|
00000000|MMI|3.42|Additional comments|C1830770|[fndg]|["Additional comments"-tx-20-"ADDITIONAL COMMENTS"-noun-1]|TX|5063/19|
00000000|MMI|3.42|Admission activity|C0809949|[hlca]|["Admission"-tx-8-"Admission"-noun-0]|TX|3123/9|
00000000|MMI|3.42|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|242/9|
00000000|MMI|3.42|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|242/9|
00000000|MMI|3.42|CH|C3715197|[fndg]|["CH"-tx-2-"CH"-noun-0]|TX|287/2|
00000000|MMI|3.42|Coating (film)|C1522408|[qlco]|["Coated"-tx-4-"COATED"-adj-0]|TX|1078/6|
00000000|MMI|3.42|Computed Tomography Study File|C3888140|[inpr]|["CT"-tx-22-"CT"-noun-0]|TX|5262/2|
00000000|MMI|3.42|Enteral|C1304890|[spco]|["Enteric"-tx-4-"ENTERIC"-adj-0]|TX|1070/7|
00000000|MMI|3.42|PSMD3 gene|C1419033|[gngm]|["S3"-tx-12-"s3"-noun-0]|TX|4267/2|
00000000|MMI|3.42|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-12-"CXR"-noun-0]|TX|4325/3|
00000000|MMI|3.42|Pounds|C0439219|[qnco]|["lbs"-tx-14-"lbs"-noun-0]|TX|4665/3|
00000000|MMI|3.42|RPS3 gene|C1335643|[gngm]|["S3"-tx-12-"s3"-noun-0]|TX|4267/2|
00000000|MMI|3.42|S3 (sacral segmental innervation)|C1179706|[blor]|["S3"-tx-12-"s3"-noun-0]|TX|4267/2|
00000000|MMI|3.42|Saint Helena Islands|C0038108|[geoa]|["SH"-tx-13-"SH"-noun-0]|TX|4488/2|
00000000|MMI|3.42|Started|C1272689|[qlco]|["Started"-tx-17-"started"-verb-0]|TX|4840/7|
00000000|MMI|3.42|Status|C0449438|[qlco]|["Status"-tx-3-"STATUS"-noun-0]|TX|296/6|
00000000|MMI|3.42|Testicular Cancer Serum Markers Test Result S3|C3812877|[lbtr]|["S3"-tx-12-"s3"-noun-0]|TX|4267/2|
00000000|MMI|3.42|liquid-based cytology (procedure)|C3161851|[lbpr]|["LBS"-tx-14-"lbs"-noun-0]|TX|4665/3|
00000000|MMI|3.39|Word finding difficulty (disorder)|C0454643|[dsyn]|["Word-finding difficulties"-tx-12-"word finding difficulties"-noun-0]|TX|4047/25|
00000000|MMI|3.39|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3056/9,3076/9|
00000000|MMI|3.39|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-8-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|3056/9,3076/9|
00000000|MMI|3.38|Entered|C1521975|[qlco]|["Entered"-tx-24-"ENTERED"-verb-0]|TX|5338/7|
00000000|MMI|3.37|Creatine kinase MB measurement|C0523584|[lbpr]|["CKMB"-tx-12-"CKMB"-noun-0]|TX|4406/4|
00000000|MMI|3.37|Disposition|C0743223|[idcn]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|314/11|
00000000|MMI|3.37|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-3-"DISPOSITION"-noun-0]|TX|314/11|
00000000|MMI|3.37|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-8-"DISCHARGE DIAGNOSIS"-noun-0]|TX|3066/19|
00000000|MMI|3.35|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2638/8|
00000000|MMI|3.35|Active|C0205177|[ftcn]|["Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2638/8|
00000000|MMI|3.35|Activities|C0441655|[acty]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2638/8|
00000000|MMI|3.35|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2638/8|
00000000|MMI|3.35|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2638/8|
00000000|MMI|3.35|Gender Status - Intact|C1554187|[fndg]|["Intact"-tx-12-"intact"-adj-0]|TX|4305/6|
00000000|MMI|3.35|Intact|C0205266|[qlco]|["Intact"-tx-12-"intact"-adj-0]|TX|4305/6|
00000000|MMI|3.35|MMP gene|C0919336|[gngm]|["MMP"-tx-8-"MMP"-noun-0]|TX|3696/3|
00000000|MMI|3.35|PACERR gene|C3890506|[gngm]|["PACER"-tx-8-"pacer"-noun-0]|TX|3246/5|
00000000|MMI|3.35|Percent Activity|C0439167|[qnco]|["% Activity"-tx-5-"ACTIVITY"-noun-0]|TX|2638/8|
00000000|MMI|3.35|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-5-"ACTIVITY"-noun-0]|TX|2638/8|
00000000|MMI|3.35|Planned|C1301732|[ftcn]|["Plan"-tx-22-"PLAN"-noun-0]|TX|5244/4|
00000000|MMI|3.35|Treatment Plan|C0599880|[inpr]|["Plan"-tx-22-"PLAN"-noun-0]|TX|5244/4|
00000000|MMI|3.35|Weights - exercise activity|C3812400|[fndg]|["Weights"-tx-21-"weights"-noun-0]|TX|5201/7|
00000000|MMI|3.35|Followed by|C0332283|[tmco]|["Followed by"-tx-8-"followed by"-verb-0]|TX|2878/11|
00000000|MMI|3.35|Phase II/III Trial|C1519042|[resa]|["2-3"-tx-12-"2.3"-real_number-0]|TX|4383/3|
00000000|MMI|3.35|Course|C0750729|[tmco]|["Course"-tx-12-"Course"-noun-0]|TX|4425/6|
00000000|MMI|3.35|MRC1 gene|C1417249|[gngm]|["MR"-tx-16-"MR"-noun-0]|TX|4718/2|
00000000|MMI|3.35|Minor Response|C4050513|[fndg]|["MR"-tx-16-"MR"-noun-0]|TX|4718/2|
00000000|MMI|3.35|Mr. - Title|C2347167|[cnce]|["Mr."-tx-16-"MR"-noun-0]|TX|4718/2|
00000000|MMI|3.35|Oxycodone measurement|C0524222|[lbpr]|["Oxycontin"-tx-4-"OXYCONTIN"-noun-0]|TX|953/9|
00000000|MMI|3.34|Experimental Finding|C2825141|[fndg]|["Finding"-tx-12-"finding"-noun-0]|TX|4184/7|
00000000|MMI|3.34|Finding|C0243095|[fndg]|["Finding"-tx-12-"finding"-noun-0]|TX|4184/7|
00000000|MMI|3.34|Term (lexical)|C1705313|[idcn]|["Word"-tx-12-"word"-noun-0]|TX|4179/4|
00000000|MMI|3.34|Allergy clinic|C3810819|[hcro,mnob]|["Allergy clinic"-tx-8-"Clinic ALLERGY"-noun-0]|TX|2899/14|
00000000|MMI|3.34|Five times weekly|C0585298|[tmco]|["Five times per week"-tx-5-"five times per week"-noun-0]|TX|1831/19|
00000000|MMI|3.33|Negative - answer|C3853545|[qlco]|["NEG"-tx-12-"neg"-noun-0]|TX|4104/3|
00000000|MMI|3.33|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|109/7|
00000000|MMI|3.33|Axial R|C3538806|[spco]|["Ra"-tx-12-"RA"-noun-0]|TX|4169/2|
00000000|MMI|3.33|Right arm|C4048756|[bpoc]|["RA"-tx-12-"RA"-noun-0]|TX|4169/2|
00000000|MMI|3.33|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|109/7|
00000000|MMI|3.33|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|109/7|
00000000|MMI|3.33|End|C0444930|[spco]|["End"-tx-27-"END"-noun-0]|TX|5418/3|
00000000|MMI|3.33|Responsible to|C1273518|[fndg]|["Responsible"-tx-8-"Responsible"-adj-0]|TX|3087/11|
00000000|MMI|3.33|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-27-"END"-noun-0]|TX|5418/3|
00000000|MMI|3.32|Dry body weight (observable entity)|C2709005|[orga]|["Dry weight"-tx-14-"dry weight"-noun-0]|TX|4634/10|
00000000|MMI|3.31|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|164/10|
00000000|MMI|3.31|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-3-"empty"-adj-0]|TX|787/5|
00000000|MMI|3.31|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|793/7|
00000000|MMI|3.31|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-3-"stomach"-noun-0]|TX|793/7|
00000000|MMI|3.31|Initially|C0205265|[tmco]|["Initially"-tx-17-"initially"-adv-0]|TX|4807/9|
00000000|MMI|3.31|Myocardial Infarction ECG Assessment|C3810814|[diap]|["MI"-tx-17-"MI"-noun-0]|TX|4763/2|
00000000|MMI|3.31|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-3-"stomach"-noun-0]|TX|793/7|
00000000|MMI|3.30|Day 2|C3842676|[fndg]|["Day 2"-tx-17-"2 day"-noun-0]|TX|4864/1,4871/3|
00000000|MMI|3.30|Day 6|C3842673|[fndg]|["Day 6"-tx-17-"6 day"-noun-0]|TX|4866/1,4871/3|
00000000|MMI|3.30|Smoker|C0337664|[fndg]|["Smoker"-tx-13-"smoker"-noun-0]|TX|4492/6|
00000000|MMI|3.30|Restart|C1514902|[qlco]|["Restart"-tx-9-"restarted"-verb-0]|TX|3855/9|
00000000|MMI|3.30|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-8-"RESUME"-noun-0]|TX|3654/6|
00000000|MMI|3.30|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-8-"RESUME"-noun-0]|TX|3654/6|
00000000|MMI|3.30|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|213/4|
00000000|MMI|3.30|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-8-"RESUME"-noun-0]|TX|3654/6|
00000000|MMI|3.29|ounce|C0439218|[qnco]|["OZ"-tx-5-"oz"-noun-0]|TX|2439/2|
00000000|MMI|3.28|1-2|C3843716|[fndg]|["1-2"-tx-7-"1-2"-integer-0]|TX|2777/3|
00000000|MMI|3.28|1/2|C0580272|[inpr]|["1/2"-tx-7-"1-2"-integer-0]|TX|2777/3|
00000000|MMI|3.28|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|200/3|
00000000|MMI|3.28|Phase I/II Trial|C1519043|[resa]|["1-2"-tx-7-"1-2"-integer-0]|TX|2777/3|
00000000|MMI|3.25|Activation-induced cell death of T cells|C3537205|[celf]|["AICD"-tx-11-"AICD"-noun-0]|TX|4010/4|
00000000|MMI|3.25|Antacid Effects|C1383090|[phsf]|["Antacid"-tx-3-"antacid"-noun-0]|TX|536/7|
00000000|MMI|3.25|Anterior thoracic region|C1527391|[blor]|["Chest"-tx-12-"chest"-noun-0]|TX|4216/5|
00000000|MMI|3.25|Automatic Implantable Cardioverter-Defibrillators|C0972395|[medd]|["aicd"-tx-11-"AICD"-noun-0]|TX|4010/4|
00000000|MMI|3.25|Causing|C0678227|[ftcn]|["Causing"-tx-8-"Causing"-adj-0]|TX|3115/7|
00000000|MMI|3.25|Deficit|C2987487|[qlco]|["deficits"-tx-12-"deficits"-noun-0]|TX|4316/8|
00000000|MMI|3.25|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|34/5|
00000000|MMI|3.25|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|34/5|
00000000|MMI|3.25|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|34/5|
00000000|MMI|3.25|Patient Class - Outpatient|C1549405|[clas]|["Outpatient"-tx-23-"outpatient"-noun-0]|TX|5291/10|
00000000|MMI|3.25|Referral category - Outpatient|C1548439|[idcn]|["Outpatient"-tx-23-"outpatient"-noun-0]|TX|5291/10|
00000000|MMI|3.25|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|238/3|
00000000|MMI|3.25|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|238/3|
00000000|MMI|3.25|activation-induced B cell apoptotic process|C2611803|[celf]|["AICD"-tx-11-"AICD"-noun-0]|TX|4010/4|
00000000|MMI|3.25|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-24-"dictated"-adj-0]|TX|5321/8|
00000000|MMI|3.25|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-24-"dictated"-adj-0]|TX|5321/8|
00000000|MMI|3.25|macrophage apoptotic process|C3156099|[celf]|["AICD"-tx-11-"AICD"-noun-0]|TX|4010/4|
00000000|MMI|3.25|BP 100|C2715713|[aapp,bacs]|["BP 100"-tx-12-"BP 100"-noun-0]|TX|4149/2,4165/3|
00000000|MMI|3.24|Pain Origin|C1518853|[clna]|["Pain Start"-tx-4-"Pain Starting"-noun-0]|TX|853/4,886/8|
00000000|MMI|3.24|mg/mg|C1319635|[qnco]|["mg/mg"-tx-4-"MG MG"-noun-0]|TX|1090/2,1115/2|
00000000|MMI|3.24|Electrocardiographic changes|C0855329|[fndg]|["ekg change"-tx-12-"EKG changes"-noun-1]|TX|4111/11|
00000000|MMI|3.24|Metoprolol Tartrate 25 MG|C2723290|[clnd]|["Metoprolol Tartrate 25 MG"-tx-3-"METOPROLOL TARTRATE 25 MG"-noun-0]|TX|685/25|
00000000|MMI|3.23|Twice weekly|C0556985|[tmco]|["Twice per week"-tx-4-"twice per week"-noun-0]|TX|1240/14|
00000000|MMI|3.23|60%|C3842585|[fndg]|["60%"-tx-12-"60"-integer-0]|TX|4445/2|
00000000|MMI|3.23|Full|C0443225|[qlco]|["Full"-tx-3-"Full"-adj-0]|TX|304/4|
00000000|MMI|3.23|Importance Weight|C1705104|[idcn]|["Weight"-tx-5-"weight"-noun-0]|TX|2535/6|
00000000|MMI|3.23|Weighing patient|C1305866|[diap]|["weight"-tx-5-"weight"-noun-0]|TX|2535/6|
00000000|MMI|3.23|chronic|C0205191|[tmco]|["CHRONIC"-tx-8-"chronic"-adj-0]|TX|3539/7|
00000000|MMI|3.22|Administration procedure|C1533734|[topp]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|3228/9|
00000000|MMI|3.22|Allopurinol 200 MG|C1126761|[clnd]|["Allopurinol 200 MG"-tx-3-"ALLOPURINOL 200 MG"-noun-0]|TX|367/18|
00000000|MMI|3.22|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|3228/9|
00000000|MMI|3.22|Device Motor|C1705994|[mnob]|["Motor"-tx-12-"motor"-noun-0]|TX|4291/5|
00000000|MMI|3.22|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-5-"PUO"-noun-0]|TX|2372/3|
00000000|MMI|3.22|Sensory (qualifier value)|C0445254|[qlco]|["Sensory"-tx-12-"sensory"-adj-0]|TX|4297/7|
00000000|MMI|3.22|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-5-"Sodium"-noun-0]|TX|2631/6|
00000000|MMI|3.22|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-5-"Sodium"-noun-0]|TX|2631/6|
00000000|MMI|3.22|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-5-"Sodium"-noun-0]|TX|2631/6|
00000000|MMI|3.22|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|3228/9|E02
00000000|MMI|3.22|Treating|C1522326|[ftcn]|["Treatment"-tx-8-"Treatment"-noun-0]|TX|3228/9|
00000000|MMI|3.22|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-8-"Treatment"-noun-0]|TX|3228/9|
00000000|MMI|3.22|gram|C0439208|[qnco]|["GRAM"-tx-5-"gram"-noun-0]|TX|2626/4|
00000000|MMI|3.22|motor movement|C1513492|[ftcn]|["Motor"-tx-12-"motor"-noun-0]|TX|4291/5|
00000000|MMI|3.22|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-8-"Treatment"-noun-0]|TX|3228/9|
00000000|MMI|3.22|Monday through Friday|C1306057|[tmco]|["M-F"-tx-3-"M F"-noun-0]|TX|654/1,658/1|
00000000|MMI|3.21|1+|C3816745|[fndg]|["1+"-tx-3-"1"-integer-0]|TX|566/1|
00000000|MMI|3.21|1+ Score|C2827734|[qnco]|["1+"-tx-3-"1"-integer-0]|TX|566/1|
00000000|MMI|3.21|1+ Score, WHO|C2981698|[clas]|["1+"-tx-3-"1"-integer-0]|TX|566/1|
00000000|MMI|3.21|55|C0450382|[inpr]|["55"-tx-16-"55"-percentage-0]|TX|4707/2|
00000000|MMI|3.21|Every twelve hours|C0585327|[tmco]|["Q12H"-tx-4-"Q12H"-noun-0]|TX|1005/4|
00000000|MMI|3.21|Flat shape|C0205324|[spco]|["Flat"-tx-12-"flat"-adj-0]|TX|4420/4|
00000000|MMI|3.21|Residential flat|C0457933|[mnob]|["Flat"-tx-12-"flat"-adj-0]|TX|4420/4|
00000000|MMI|3.21|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-4-"TAB"-noun-0]|TX|942/3|
00000000|MMI|3.21|Unit|C0439148|[qnco]|["UNITS"-tx-4-"UNITS"-noun-0]|TX|1041/5|
00000000|MMI|3.21|Unit - NCI Thesaurus Property|C3853603|[ftcn]|["Units"-tx-4-"UNITS"-noun-0]|TX|1041/5|
00000000|MMI|3.21|Unit of Measure|C1519795|[qnco]|["Units"-tx-4-"UNITS"-noun-0]|TX|1041/5|
00000000|MMI|3.21|2/5|C0450346|[qnco]|["2 5"-tx-3-"2.5"-real_number-0]|TX|636/3|
00000000|MMI|3.21|Ischemic|C0475224|[ftcn]|["Ischemic"-tx-8-"ischemic"-adj-0]|TX|3710/8|
00000000|MMI|3.21|Primary|C0205225|[qlco]|["Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|3056/9|
00000000|MMI|3.21|Teaching principal|C0401925|[prog]|["Principal"-tx-8-"PRINCIPAL"-adj-0]|TX|3056/9|
00000000|MMI|3.21|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-5-"chol"-noun-0]|TX|2600/4|
00000000|MMI|3.21|Every eight hours|C0585326|[tmco]|["Q8H"-tx-4-"Q8H"-noun-0]|TX|820/3|
00000000|MMI|3.21|Home environment|C0442519|[cnce]|["house"-tx-5-"House"-noun-0]|TX|2588/5|
00000000|MMI|3.21|House (environment)|C2003847|[mnob]|["House"-tx-5-"House"-noun-0]|TX|2588/5|
00000000|MMI|3.21|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-5-"sat"-noun-0]|TX|2609/3|
00000000|MMI|3.21|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-5-"sat"-noun-0]|TX|2609/3|
00000000|MMI|3.21|Table Frame - above|C1552828|[idcn]|["above"-tx-12-"above"-adj-0]|TX|4031/5|
00000000|MMI|3.21|Upper|C1282910|[spco]|["Above"-tx-12-"above"-adj-0]|TX|4031/5|
00000000|MMI|3.21|liter|C0475211|[qnco]|["LITER"-tx-5-"liters"-noun-0]|TX|2575/6|
00000000|MMI|3.20|K Prime|C1708601|[qnco]|["K'"-tx-12-"K"-noun-0]|TX|4093/1|
00000000|MMI|3.20|Potassium Ion|C0597277|[elii,phsu]|["K+"-tx-12-"K"-noun-0]|TX|4093/1|
00000000|MMI|3.20|71|C0450389|[inpr]|["71"-tx-1-"71"-integer-0]|TX|91/2|
00000000|MMI|3.20|80%|C3842583|[fndg]|["80%"-tx-12-"80"-integer-0]|TX|4162/2|
00000000|MMI|3.20|10%|C3842590|[fndg]|["10%"-tx-4-"10"-integer-0]|TX|1112/2|
00000000|MMI|3.20|Hospital course|C0489547|[fndg]|["Hospital course"-tx-8-"HOSPITAL COURSE"-noun-1]|TX|3664/15|
00000000|MMI|3.20|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-8-"HOSPITAL COURSE"-noun-0]|TX|3664/15|
00000000|MMI|3.20|Room of building - Study|C0557651|[mnob]|["Study"-tx-8-"Study"-noun-0]|TX|3105/5|
00000000|MMI|3.20|Study|C2603343|[resa]|["Study"-tx-8-"Study"-noun-0]|TX|3105/5|
00000000|MMI|3.20|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-4-"ATORVASTATIN"-noun-0]|TX|1099/12|
00000000|MMI|3.20|Weekly|C0332174|[tmco]|["/week"-tx-3-"Week"-noun-0]|TX|649/4|
00000000|MMI|3.20|0%|C3842591|[fndg]|["0%"-tx-3-"0"-real_number-0]|TX|403/1|
00000000|MMI|3.20|100%|C3817553|[qnco]|["100%"-tx-3-"100"-integer-0]|TX|443/3|
00000000|MMI|3.19|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|118/3|
00000000|MMI|3.19|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|118/3|
00000000|MMI|3.19|Hairy/Enhancer-Of-Split Related With YRPW Motif Protein 2|C3538964|[aapp,bacs]|["HRT-2"-tx-12-"HRT 2"-noun-0]|TX|4228/5|
00000000|MMI|3.19|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|118/3|
00000000|MMI|3.19|MAGNESIUM GLUCONATE 500 MG|C1124051|[clnd]|["MAGNESIUM GLUCONATE 500 MG"-tx-5-"MAGNESIUM GLUCONATE 500 MG"-noun-0]|TX|2301/26|
00000000|MMI|3.18|New|C0205314|[qlco]|["NEW"-tx-12-"new"-adj-0]|TX|4352/3|
00000000|MMI|3.18|Past|C1444637|[tmco]|["Past"-tx-13-"past"-adj-0]|TX|4502/4|
00000000|MMI|3.18|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-8-"BRIEF"-adj-0]|TX|3648/5|
00000000|MMI|3.18|Brief|C1879313|[tmco]|["Brief"-tx-8-"BRIEF"-adj-0]|TX|3648/5|
00000000|MMI|3.18|Only - dosing instruction fragment|C1720467|[inpr]|["Only"-tx-4-"only"-adv-0]|TX|1255/4|
00000000|MMI|3.18|Shortened|C1282927|[qlco]|["brief"-tx-8-"BRIEF"-adj-0]|TX|3648/5|
00000000|MMI|3.18|Singular|C0205171|[qnco]|["Only"-tx-4-"only"-adv-0]|TX|1255/4|
00000000|MMI|3.18|Ischemic Change|C2826576|[fndg]|["Ischemic Change"-tx-13-"ischemic change"-noun-0]|TX|4518/8,4576/6|
00000000|MMI|3.18|Back structure, excluding neck|C1995000|[blor]|["Back, NOS"-tx-14-"back"-adj-0]|TX|4626/4|
00000000|MMI|3.18|Back structure, including back of neck|C0460009|[blor]|["Back"-tx-14-"back"-adj-0]|TX|4626/4|
00000000|MMI|3.18|Dorsal|C0205095|[spco]|["BACK"-tx-14-"back"-adj-0]|TX|4626/4|
00000000|MMI|3.18|Harsh|C4068826|[fndg]|["Harsh"-tx-12-"harsh"-adj-0]|TX|4236/5|
00000000|MMI|3.18|Highest|C1522410|[qlco]|["Apex"-tx-12-"apex"-noun-0]|TX|4249/4|
00000000|MMI|3.18|Radiography Study File|C3891450|[inpr]|["RAD"-tx-12-"rad"-noun-0]|TX|4254/3|
00000000|MMI|3.18|dinoflagellate apex|C3890171|[celc]|["apex"-tx-12-"apex"-noun-0]|TX|4249/4|
00000000|MMI|3.18|ribosome-associated ubiquitin-dependent protein catabolic process|C3811628|[celf]|["RAD"-tx-12-"rad"-noun-0]|TX|4254/3|
00000000|MMI|3.17|Decompensated|C0205434|[qlco]|["Decompensated"-tx-13-"decompensated"-adj-0]|TX|4533/13|
00000000|MMI|3.17|contextual factors|C0542559|[ftcn]|["Setting"-tx-13-"setting"-noun-